Phase II colorectal cancer clinical trial first to receive support, scientific oversight from Van Andel Research Institute-Stand Up To Cancer Epigenetics Dream Team

(Van Andel Research Institute) The first clinical trial to move forward as part of the Van Andel Research Institute-Stand Up To Cancer Epigenetics Dream Team will target metastatic colorectal cancer, the second leading cause of cancer deaths among men and women combined in the US.